MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the label strategy for sonelokimab (SLK) in hidradenitis suppurativa (HS)This included the acceptability of MIRA trial data to establish substantial evidence of effectiveness (SEE), full inclusion of the VELA-TEEN trial data for a label including patients aged 12 years and above, and the strategy for inclu

A first-of-its-kind program makes initial fertility evaluations, monitoring, and more available at in-network OB/GYNs – expanding access for the millions of Americans who live more than 100 miles from an IVF specialist WEST DES MOINES, Iowa, May 10, 2026 /PRNewswire/ -- Today, there are approximately 1,500 board-certified Reproductive Endocrinology and Infertility (REI) subspecialists in the United States, with only about 1,250 in active practice, and more than 40,000 OB/GYNs. For the 35 million

Scientists at the University of Rochester pulled off a remarkable experiment: they transferred a longevity-related gene from the famously long-lived naked mole rat into mice, and the mice ended up healthier and lived longer. The special gene boosts production of a substance called high molecular weight hyaluronic acid, which appears to protect against cancer, reduce inflammation, and support healthier aging. The modified mice showed stronger resistance to tumors, healthier guts, and lower levels

The investments will cover advanced pharmaceutical ingredients (API) as well as genetic medicine manufacturing. Credit: Lilly Eli Lilly is investing an additional US$4.5bn to expand its Lebanon, Indiana sites for GLP-1 drugs and genetic medicines amid surging demand growth Eli Lilly and Company has committed an additional US$4.5bn to expand two of its three Lebanon sites in Indiana, US. The pharmaceutical manufacturer now has total capital expansion commitments exceeding US$21bn since 2020. The

Scientists have uncovered a hidden “stop-scratching” signal in the nervous system that tells your brain when enough scratching is enough. The discovery centers on a molecule called TRPV4, which acts like part of an internal braking system for itch relief. In experiments involving chronic itch similar to eczema, mice missing this signal scratched less often—but when they did scratch, they couldn’t stop.When an itch strikes, scratching usually brings relief after a few moments. Scientists have now

Scientists have uncovered a striking brain difference linked to psychopathy: people with psychopathic traits were found to have a striatum — a brain region tied to reward, motivation, and decision-making — that was about 10% larger on average than those without such traits. Using MRI scans and psychological assessments on 120 participants, researchers connected this enlarged brain region to thrill-seeking, impulsive behavior, and a stronger drive for stimulation.Neuroscientists have identified a

RICHMOND, Va., May 9, 2026 /PRNewswire/ -- NIRSense, Inc. today announced its participation in Balikatan-26, supporting the US Army Pacific (USARPAC)'s 18th Theater Medical Command (18th TMC) as they evaluate advanced approaches to battlefield casualty assessment using portable tissue oxygen saturation (StO₂) monitoring. Continue Reading Dr. Robert Furberg, center, explains operation of a care delivery platform software system and NIRSense Aegis X0 wireless data transmitter to U.S. Airmen during

BASEL, Switzerland, May 9, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discovery and development. As essential tools for innovative drug R&D, functional cell lines need clear, accessible usage authorization to keep projects on track. The updated policy expands authori

New data demonstrates ULTRApulse Alpha® CO2 effectiveness on patients with rhinophyma E‑poster highlights improved skin appearance and lesion clearance outcomes achieved with enhanced Stellar M22™ XPL technology Non-ablative Fractional 1565nm Laser Data supports FoLix™ efficacy in treating patients living with androgenic alopecia YOKNEAM, Israel, May 9, 2026 /PRNewswire/ -- Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced new clin

Welcome back to another edition of Endpoints Weekly! Earnings season is in full swing, but we had plenty of original reporting and exclusives you won’t find anywhere else this week. Chief among them: Andrew Dunn’s excellent story Friday on why biopharma is struggling to recruit young AI talent . Spoiler — it’s not just the pay gap with companies like OpenAI, though that’s definitely part of it. We also hosted a Post-Hoc Live recapping what we’ve seen in earnings so far, where I joined Drew Armst